Urmăriți
Lindomar Pena
Lindomar Pena
Pesquisador em Saúde Pública Fundação Oswaldo Cruz (Fiocruz)-PE/CPqAM
Adresă de e-mail confirmată pe cpqam.fiocruz.br - Pagina de pornire
Titlu
Citat de
Citat de
Anul
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza
J Steel, AC Lowen, L Pena, M Angel, A Solórzano, R Albrecht, DR Perez, ...
Journal of virology 83 (4), 1742-1753, 2009
3002009
Computed tomographic findings in microcephaly associated with Zika virus
AN Hazin, A Poretti, D Di Cavalcanti Souza Cruz, M Tenorio, ...
New England Journal of Medicine 374 (22), 2193-2195, 2016
2912016
Human metapneumovirus: review of an important respiratory pathogen
S Panda, NK Mohakud, L Pena, S Kumar
International journal of infectious diseases 25, 45-52, 2014
2582014
Zika virus replication in the mosquito Culex quinquefasciatus in Brazil
DRD Guedes, MHS Paiva, MMA Donato, PP Barbosa, L Krokovsky, ...
Emerging microbes & infections 6 (1), 1-11, 2017
2552017
Full genome sequence and sfRNA interferon antagonist activity of Zika virus from Recife, Brazil
CL Donald, B Brennan, SL Cumberworth, VV Rezelj, JJ Clark, ...
PLoS neglected tropical diseases 10 (10), e0005048, 2016
2492016
Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil.
MT Cordeiro, LJ Pena, CA Brito, LH Gil, ET Marques
1682016
Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species
M Schmolke, B Manicassamy, L Pena, T Sutton, R Hai, ZT Varga, BG Hale, ...
PLoS pathogens 7 (8), e1002186, 2011
1582011
Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil
SJR Da Silva, L Pena
One Health 13, 100287, 2021
1472021
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure …
S Kumar, PP Sharma, U Shankar, D Kumar, SK Joshi, L Pena, ...
Journal of Chemical Information and Modeling 60 (12), 5754-5770, 2020
1472020
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?
J Ye, EM Sorrell, Y Cai, H Shao, K Xu, L Pena, D Hickman, H Song, ...
PLoS pathogens 6 (10), e1001145, 2010
1392010
Deceptive imprinting and immune refocusing in vaccine design
GJ Tobin, JD Trujillo, RV Bushnell, G Lin, AR Chaudhuri, J Long, ...
Vaccine 26 (49), 6189-6199, 2008
1342008
Loop-mediated isothermal amplification (LAMP) for the diagnosis of Zika virus: a review
SJR Silva, K Pardee, L Pena
Viruses 12 (1), 19, 2019
1282019
Two years into the COVID-19 pandemic: lessons learned
SJR da Silva, JCF do Nascimento, RP Germano Mendes, KM Guarines, ...
ACS infectious diseases 8 (9), 1758-1814, 2022
1222022
Lessons learned at the epicenter of Brazil’s congenital Zika epidemic: evidence from 87 confirmed cases
JA Meneses, AC Ishigami, LM de Mello, LL de Albuquerque, CAA de Brito, ...
Clinical Infectious Diseases 64 (10), 1302-1308, 2017
1202017
Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen
MJ Grubman, MP Moraes, F Diaz-San Segundo, L Pena, T De Los Santos
FEMS Immunology & Medical Microbiology 53 (1), 8-17, 2008
1202008
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses
L Pena, AL Vincent, J Ye, JR Ciacci-Zanella, M Angel, A Lorusso, ...
Journal of virology 85 (1), 456-469, 2011
1152011
Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19
SJR da Silva, CTA Silva, KM Guarines, RPG Mendes, K Pardee, A Kohl, ...
ACS infectious diseases 6 (9), 2319-2336, 2020
1082020
A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens
EM Sorrell, H Song, L Pena, DR Perez
Journal of virology 84 (22), 11831-11840, 2010
1072010
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
FR Formiga, R Leblanc, J de Souza Rebouças, LP Farias, RN de Oliveira, ...
Journal of controlled release 329, 758-761, 2021
1022021
In vitro and in vivo models for studying SARS-CoV-2, the etiological agent responsible for COVID-19 pandemic
RB Rosa, WM Dantas, JCF do Nascimento, MV da Silva, RN de Oliveira, ...
Viruses 13 (3), 379, 2021
822021
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20